A New Model for Studying HER2/neu Breast Cancer
Author Information
Author(s): Marie P. Piechocki
Primary Institution: Wayne State University and Karmanos Cancer Center
Hypothesis
The study aims to evaluate the effects of therapeutic agents on the tumor microenvironment in invasive cancers using a co-culture model.
Conclusion
The MAM-1 model demonstrates the specificity of Iressa for HER2/neu expressing tumor cells and highlights the differential responses of tumor and stromal cells to treatment.
Supporting Evidence
- The MAM-1 model maintains a 1:1 ratio of tumor to stromal cells for over 20 passages.
- Iressa treatment resulted in a selective reduction of tumor cell markers while increasing stromal cell markers.
- Flow cytometric analysis showed distinct populations of tumor and stromal cells in the co-culture.
Takeaway
Researchers created a special lab model to study how a cancer drug affects breast cancer cells and their surrounding support cells, finding that the drug works better on the cancer cells than on the support cells.
Methodology
The study used a co-culture model of HER2/neu positive tumor cells and alpha-SMA expressing stromal cells, characterized by microarray analysis and flow cytometry.
Limitations
The model may not fully replicate the complexity of in vivo tumor microenvironments.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website